News | April 25, 2007

Iapyx Medical Introduces Catheter Stabilization Devices to Minimize Complication, Infections

April 26, 2007 - Iapyx Medical introduced its Stable-Line family of catheter stabilization products designed to minimize the risk of catheter-related bloodstream and urinary tract infections, two of the three most common hospital-acquired infections.

With the launch of Stable-Line Arterial and Stable-Line Foley catheter stabilization devices, Iapyx Medical aims to combat the epidemic of hospital-acquired infections and improve patient care and clinician safety.

The Stable-Line Arterial catheter stabilization device is designed to prevent inadvertent movement and dislodgment of arterial lines. Suture securement, the traditional means of arterial line securement, increases patients' risks of developing catheter-related bloodstream infections (CRBSI), which pose a significant mortality risk.

Suture securement also puts healthcare workers at risk for needlestick injuries, which expose them to blood-borne pathogens including Hepatitis B, Hepatitis C and HIV. The Stable-Line Arterial device mitigates these risks while addressing OSHA's recommendation for sutureless securement and meeting Infusion Nurses Society (INS) standards as a manufactured stabilization device. Without the use of invasive sutures or conventional strips of tape, the Stable-Line Arterial catheter stabilization device firmly grips the extension set to immobilize the catheter while permitting visual inspection and monitoring of the insertion site.

For more information visit www.iapyx.com.

Related Content

Non-Contrast MRI Effective in Monitoring MS Patients
News | Neuro Imaging | March 18, 2019
Brain magnetic resonance imaging (MRI) without contrast agent is just as effective as the contrast-enhanced approach...
Ultrasound Societies Urge FDA to Remove "Black Box" on Ultrasound Contrast Agents
News | Ultrasound Imaging | March 07, 2019
National and international ultrasound societies are urging the U.S. Food and Drug Administration to remove the “black...
Sponsored Content | Case Study | Contrast Media | January 30, 2019
The medical imaging market relies heavily on contrast media, injected into patients to increase the contrast of bodil
Sponsored Content | Videos | Contrast Media | January 22, 2019
ITN Contributing Editor Greg Freiherr speaks with Guerb
Videos | Artificial Intelligence | December 21, 2018
Enhao Gong, Ph.D., founder of Subtle Medical, an artificial intelligence (AI) company that develops products to help
Guerbet Showcases Diagnostic and Interventional Imaging Solutions at RSNA 2018
News | Interventional Radiology | December 12, 2018
Guerbet LLC USA highlighted new and next-level product offerings and partnerships in contrast media, injectors,...
Guerbet Launches Multi-Use OptiVantage Contrast Media Injector in Europe
Technology | Contrast Media Injectors | December 05, 2018
Contrast agent company Guerbet recently announced that the OptiVantage multi-use contrast media injector is now CE...
VigiLanz and Cincinnati Children's Commercialize Real-Time Acute Kidney Injury Tracking
News | Contrast Media | November 30, 2018
VigiLanz and Cincinnati Children’s Hospital Medical Center recently announced a collaboration that leverages Cincinnati...
Artificial Intelligence May Help Reduce Gadolinium Dose in MRI

Example of full-dose, 10 percent low-dose and algorithm-enhanced low-dose. Image courtesy of Enhao Gong, Ph.D.

News | Contrast Media | November 27, 2018
Researchers are using artificial intelligence (AI) to reduce the dose of a contrast agent that may be left behind in...
Guerbet Showcases Ongoing Collaboration With IBM Watson at RSNA 2018
News | Clinical Decision Support | November 21, 2018
Guerbet LLC USA will feature its digital solutions including its ongoing collaboration with IBM Watson Health in...